Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Human SAA Kit enables the measurement of SAA in a single-analyte format. For information on multiplexing SAA with other analytes, please see
V-PLEX Plus Vascular Injury Panel 2 Human Kit.V-PLEX Plus kits include controls, wash buffer, and plate seals.
Related Key Terms:
Neurobiology/Neurodegeneration, serum amyloid A, SAA
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cardiovascular
|
|
|
Analyte(s)
|
|
SAA
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
|
Detection Antibody
|
|
Mouse Monoclonal
|
|
|
LLOD (Sensitivity)
|
|
10.9 pg/mL
|
|
|
Dynamic Range
|
|
10.9 - 138,000 pg/mL
|
|
|
Sample Type
|
|
Serum, Plasma, Urine, Cell Culture Supernatant
|
|
|
Recombinant standards
|
|
Expressed in Wheat germ extract
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
6288, 6289
|
|
|
UniProt ID(s)
|
|
P0DJI8, P0DJI9
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Vascular Injury Control 1
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Vascular Injury Control 2
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Vascular Injury Control 3
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Vascular Injury Panel 2 (human) Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
2-8 °C
|
2 bottle
(50 mL)
|
|
|
|
Diluent 101, 30 mL
|
≤-10 °C
|
1 bottle
(NA bottle)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Vascular Injury Control 1
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Vascular Injury Control 2
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Vascular Injury Control 3
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Vascular Injury Panel 2 (human) Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
2-8 °C
|
2 bottle
(200 mL)
|
|
|
|
Diluent 101, 150 mL
|
≤-10 °C
|
1 bottle
(NA bottle)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Vascular Injury Control 1
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Vascular Injury Control 2
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Vascular Injury Control 3
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Vascular Injury Panel 2 (human) Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
|
2-8 °C
|
7 bottle
(200 mL)
|
|
|
|
Diluent 101, 150 mL
|
≤-10 °C
|
5 bottle
(NA bottle)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
View More
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Effects of a Synbiotic on Symptoms, and Daily Functioning in Attention Deficit Hyperactivity Disorder - A Double-Blind Randomized Controlled Trial
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
|
|
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
Decrease of circulating SAA is correlated with reduction of abdominal SAA secretion during weight loss.
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters